TANNQUILYNNE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TANNQUILYNNE Trademark

Serial Number: 87914117 • Registration: 6303591

TANNQUILYNNE is a trademark filed by SyneuRx International (Taiwan) Corp. on May 9, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SyneuRx International (Taiwan) Corp. (10 trademarks)

20F.-10, No.99, Sec. 1
New Taipei City 221 , TW

Entity Type: 03

SYNEURX NEUROSCIENCE (4 trademarks)

CRICKET SQUARE, HUTCHINS DRIVE, PO BOX 2681, GRAND CAYMAN, KY1- 1111
GRAND CAYMAN , KY

Entity Type: 16

Trademark Details

Filing Date

May 9, 2018

Registration Date

March 30, 2021

Published for Opposition

January 12, 2021

Goods & Services

Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Phenol for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Syrups for pharmaceutical purposes for the treatment of dementia; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating sunburn; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Medicinal herbal extracts for medical purposes; Antibacterial substances for medical purposes; Transdermal patches featuring medication for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plant; Herbal extracts for medical purposes; Phytotherapy preparations for medical purposes; Appetite suppressants for medical purposes; Beverages containing tannic acid for use as a nutritional supplement; Liquid nutritional supplement; Dietary and nutritional supplements; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of tannic acid; Dietary and nutritional supplements used for weight loss; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritional supplement for eliminating toxins from the body; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Powdered nutritional supplement drink mix containing tannic acid; Nutritional supplements for cats, dogs; Nutraceuticals for use as a dietary supplement for cognitive impairment; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 30, 2026 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 21, 2026 ASGN
REGISTERED-PRINCIPAL REGISTER
Mar 30, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 23, 2020 NONP
CASE RETURNED TO EXAMINATION
Dec 9, 2020 OTHE
NOTICE OF ALLOWANCE CANCELLED
Dec 9, 2020 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Dec 2, 2020 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Dec 2, 2020 PCBG
ASSIGNED TO PETITION STAFF
Dec 1, 2020 APET
ASSIGNED TO EXAMINER
Nov 2, 2020 DOCK
TEAS PETITION TO AMEND BASIS RECEIVED
Oct 1, 2020 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2020 EXRA
SOU EXTENSION 3 GRANTED
Jul 26, 2020 EX3G
SOU EXTENSION 3 FILED
Jul 26, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 26, 2020 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 24, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 24, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 24, 2020 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2020 EXRA
SOU EXTENSION 2 GRANTED
Jan 3, 2020 EX2G
SOU EXTENSION 2 FILED
Jan 3, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 3, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 19, 2019 EXRA
SOU EXTENSION 1 GRANTED
Jul 17, 2019 EX1G
SOU EXTENSION 1 FILED
Jul 17, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 17, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 29, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 4, 2018 NPUB
PUBLISHED FOR OPPOSITION
Dec 4, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 14, 2018 NONP
ASSIGNED TO LIE
Oct 27, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 13, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 5, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 5, 2018 GNRT
NON-FINAL ACTION WRITTEN
Sep 5, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2018 NWOS
NEW APPLICATION ENTERED
May 12, 2018 NWAP